Access cutting-edge high grade glioma treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access high grade glioma specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related high grade glioma treatment provided free
This is a multicenter, open-label study of DB107-RRV (formerly Toca 511) and DB107-FC (formerly Toca FC) when administered following surgical resection in newly diagnosed High Grade Glioma (HGG) patients. The study is designed to evaluate whether treatment with DB107-RRV in combination with DB107-FC when added to standard of care provides clinical benefit to newly diagnosed HGG when compared to historical performance previously determined in well controlled clinical trials published in the peer
Sponsor: University of California, San Francisco
Check if you qualify for this high grade glioma clinical trial in San Francisco, CA
If you're searching for high grade glioma treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced high grade glioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.